000 | 01728 a2200493 4500 | ||
---|---|---|---|
005 | 20250515150716.0 | ||
264 | 0 | _c20091125 | |
008 | 200911s 0 0 eng d | ||
022 | _a1357-0560 | ||
024 | 7 |
_a10.1007/s12032-008-9131-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aIbrahim, Ezzeldin | |
245 | 0 | 0 |
_aBasal vs. luminal A breast cancer subtypes: a matched case-control study using estrogen receptor, progesterone receptor, and HER-2 as surrogate markers. _h[electronic resource] |
260 |
_bMedical oncology (Northwood, London, England) _c2009 |
||
300 |
_a372-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
650 | 0 | 4 |
_aBreast Neoplasms _xclassification |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
650 | 0 | 4 |
_aReceptors, Estrogen _xmetabolism |
650 | 0 | 4 |
_aReceptors, Progesterone _xmetabolism |
700 | 1 | _aAl-Gahmi, Aboelkhair M | |
700 | 1 | _aZeenelin, Ahmed A | |
700 | 1 | _aZekri, Jamal M | |
700 | 1 | _aElkhodary, Tawfik R | |
700 | 1 | _aGaballa, Hussein E | |
700 | 1 | _aFawzy, Ehab E | |
700 | 1 | _aEl sayed, Mohamed E | |
700 | 1 | _aAlzahrani, Mohamed S | |
773 | 0 |
_tMedical oncology (Northwood, London, England) _gvol. 26 _gno. 3 _gp. 372-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12032-008-9131-6 _zAvailable from publisher's website |
999 |
_c18490477 _d18490477 |